Literature DB >> 32242

Assessment of the neuroleptic potential of some novel benzamide, butyrophenone, phenothiazine and indole derivatives.

B Costall, W H Funderburk, C A Leonard, R J Naylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 32242     DOI: 10.1111/j.2042-7158.1978.tb13390.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  7 in total

1.  Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study.

Authors:  J A Stamford; Z L Kruk; J Millar
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

2.  BRL 20596, a novel anilide with central dopamine antagonist activity.

Authors:  W Campbell; M S Clark; P J Mitchell; P L Needham; J M Semple
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay.

Authors:  A Mizuchi; N Kitagawa; Y Miyachi
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Characterization of 3H-GABA receptor binding to rat brain synaptosomal membranes: effect of non GABAergic compounds.

Authors:  J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

5.  Dopamine receptors in canine caudate nucleus.

Authors:  H Maeno
Journal:  Mol Cell Biochem       Date:  1982-03-19       Impact factor: 3.396

6.  Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity.

Authors:  S Usuda; K Nishikori; O Noshiro; H Maeno
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Further evidence that 3H-cis(Z)flupenthixol binds to the adenylate cyclase-associated dopamine receptor (D-1) in rat corpus striatum.

Authors:  J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.